Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-01-10
2006-01-10
Guzo, David (Department: 1636)
Chemistry: molecular biology and microbiology
Vector, per se
C435S235100, C536S023100, C536S023200, C536S023720, C536S024100
Reexamination Certificate
active
06984517
ABSTRACT:
The present invention provides an adeno-associated virus 5 (AAV5) virus and vectors and particles derived therefrom. In addition, the present invention provides methods of delivering a nucleic acid to a cell using the AAV5 vectors and particles.
REFERENCES:
patent: 44 36 664 (1996-07-01), None
patent: WO 93/24641 (1993-12-01), None
patent: WO 95/11997 (1995-05-01), None
patent: WO 96/00587 (1996-01-01), None
patent: WO 96/15777 (1996-05-01), None
patent: WO 98/11244 (1998-03-01), None
patent: WO 98/41240 (1998-09-01), None
patent: WO 98/45462 (1998-10-01), None
J.A. Chiorini et al. “Cloning and Characterization of Adeno-Associated Virus, Type 5”J. Virol.73(:2):1309-1319, Feb. 1999.
M. Konkal et al. “Characterization of the Rep78/Adeno-Associated Virus (AAV) Complex”Virol.229:183-192, 1997.
Y. Maeda et al. “Gene Transfer into Vascular Cells Using Adeno-Associated Virus (AAV) Vectors”Cardiovascular Research35:514-522, 1997.
M.J. During et al. “AAV Vectors for Gene Therapy of Neurodegenerative Disorders”Clinical Neuroscience3(5):292-300, 1996.
S.R.M. Kyostio et al. “Analysis of Adeno-Associated Virus (AAV) Wild-Type and Mutant Rep Proteins for Their Ability to Negatively Regulate AAV p5and p19mRNA Levels”J. Virol.68(5):2947-2957, 1994.
Database EMBL, Entry GGACTAA, Accession No. M61166, Mar. 27, 1991.
D.S. Im et al. “Partial Purification of Adeno-Associated Virus Rep 78, Rep52 and Rep40 and their Biochemical Characterization”J. Virol.66(2):1119-1128, Feb. 1992.
R. J. Samulski et al. “Helper-Free Stocks of Recombinant Adeno-Associated Viruses: Normal Integration Does Not Require Viral Gene Expression”J. Virol.63(9):3822-3828, Sep. 1989.
B. Georg-Fries et al. “Analysis of Proteins, Helper Dependence and Seroepidemiology of a New Human Parvovirus”Virology134:64-71, 1984.
Chiorini John A.
Kotin Robert M.
Guzo David
Needle & Rosenberg PC
The United States of America as represented by the Department of
LandOfFree
AAV5 vector and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with AAV5 vector and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AAV5 vector and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3527126